Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Brazil Potash prices $55M public offering of shares and warrants to fund Autazes potash project.

Company Fundamentals
01 May 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Brazil Potash Corp. announced a $55 million public offering of 3.7 million common shares and pre-funded warrants to support its Autazes potash project in Brazil. The offering includes an option for underwriters to buy an additional 3.3 million shares and is expected to close by May 4, 2026. Proceeds will be used for working capital and general corporate purposes as the company advances its plan to supply sustainable potash fertilizer domestically, reducing Brazil's reliance on imports. This project aims to produce up to 2.4 million tons of potash annually, potentially meeting 20% of Brazil's demand and lowering greenhouse gas emissions.

More News

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...

Company Fundamentals
Bullish
20 minutes ago
BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...

Market News
Bullish
20 minutes ago
Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics, a biopharmaceutical company specializing in next-generation T cell therapies, announced it will present at two upcoming investor conferences: William Blair’s Growth Stock Conference on June 2 and Jefferies Global Healthcare Conf...

Market News
Neutral
20 minutes ago
Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...

Market News
Bullish
20 minutes ago
Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Girard Sharp LLP is investigating potential securities claims for former Discover investors who received Capital One shares after Capital One acquired Discover in May 2025. Since the merger, Capital One's stock price has declined, leading to possible...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App